NYMOX PHARMACEUTICAL CORP's ticker is NYMX and the CUSIP is 67076P102. A total of 32 filers reported holding NYMOX PHARMACEUTICAL CORP in Q4 2013. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2015 | $22,000 | +22.2% | 6,297 | -54.0% | 0.00% | – |
| Q2 2015 | $18,000 | +500.0% | 13,696 | +295.6% | 0.00% | – |
| Q1 2015 | $3,000 | -25.0% | 3,462 | -68.4% | 0.00% | – |
| Q4 2014 | $4,000 | -73.3% | 10,969 | +212.1% | 0.00% | – |
| Q3 2014 | $15,000 | -73.2% | 3,515 | -65.6% | 0.00% | -100.0% |
| Q1 2014 | $56,000 | -40.4% | 10,230 | -33.6% | 0.00% | 0.0% |
| Q4 2013 | $94,000 | +17.5% | 15,417 | +27.5% | 0.00% | -50.0% |
| Q3 2013 | $80,000 | +73.9% | 12,095 | +35.6% | 0.00% | +100.0% |
| Q2 2013 | $46,000 | – | 8,922 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MARATHON CAPITAL MANAGEMENT | 41,650 | $253,000 | 0.18% |
| Eidelman Virant Capital | 27,796 | $169,000 | 0.07% |
| WMS Partners, LLC | 63,350 | $384,000 | 0.06% |
| SHEPHERD KAPLAN KROCHUK, LLC | 62,742 | $381,000 | 0.05% |
| Brown Advisory Securities, LLC | 10,000 | $61,000 | 0.02% |
| CROFT-LEOMINSTER INC | 20,000 | $121,000 | 0.02% |
| GSA CAPITAL PARTNERS LLP | 15,479 | $94,000 | 0.01% |
| GOFEN & GLOSSBERG LLC /IL/ | 25,000 | $152,000 | 0.01% |
| CANADA PENSION PLAN INVESTMENT BOARD | 120,913 | $734,000 | 0.00% |
| Virtu KCG Holdings LLC | 23,325 | $140,000 | 0.00% |